99% Savings - Buy Just @1 Rs X
Macmika 250 Injection is a commercial drug that is prescribed in the form of Injection. Primarily, it is used for the treatment of Urinary Tract Infection. Secondary and off-label uses of Macmika 250 Injection have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Macmika 250 Injection. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Macmika 250 Injection side effects, there are can be others also. These have been listed below. Such side effects of Macmika 250 Injection normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Macmika 250 Injection has a Severe effect for pregnant women and Unknown effect on lactating mothers. It is important to know if Macmika 250 Injection has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Macmika 250 Injection related warnings section.
Macmika 250 Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Macmika 250 Injection in conditions like Dehydration, Parkinson's Disease, Hearing Loss. Some other conditions that can be affected by Macmika 250 Injection are listed in the contraindications section below.
Additionally, Macmika 250 Injection may also adversely react with other medicines. See below for a complete list.
You should also be aware that Macmika 250 Injection is safe while driving, and is addiction.
Macmika 250 Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
2 - 12 years (Child) |
|
Is the use of Macmika 250 Injection safe for pregnant women?
Macmika can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Macmika 250 Injection safe during breastfeeding?
Information about safety of Macmika for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Macmika 250 Injection on the Kidneys?
There may be some severe side effects of Macmika on your kidney. Do not take it unless a doctor says so.
What is the effect of Macmika 250 Injection on the Liver?
Macmika is rarely harmful for the liver.
What is the effect of Macmika 250 Injection on the Heart?
Macmika is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Macmika 250 Injection unless your doctor advises you to do so -
Is this Macmika 250 Injection habit forming or addictive?
Forming a habit of Macmika 250 Injection has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Macmika 250 Injection as it does not make you drowsy.
Is it safe?
Macmika 250 Injection is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Macmika 250 Injection cannot treat any kind of mental disorder.
Interaction between Food and Macmika 250 Injection
Taking Macmika 250 Injection with food does not harm your health.
Interaction between Alcohol and Macmika 250 Injection
No research has been done on this till date. Therefore, it is not known what the effect of taking Macmika 250 Injection with alcohol will be.
Yes, Macmika is nephrotoxic. Nephrotoxicity depends on dose and duration of therapy. Thus, nephrotoxicity is likely to occur if Macmika taken a high dose for a long time or may occur if the drug is given to a patient that already suffer from kidney problem. Nephrotoxicity associated with this drug may reduce or minimize by taking some precaution before consuming this drug like monitor kidney functions regularly and do not take it in high doses. Avoid taking Macmika with another nephrotoxic drug. If you notice any urine discoloration after taking this drug then inform your doctor immediately.
No, Macmika does not cause constipation in patients who are taking it. However, if you are experiencing constipation after taking this drug then inform your doctor and take precautionary methods such as eating fibrous foods to avoid constipation.
Yes, Macmika has been reported to cause diarrhoea and it is a common side effect of this medicine. Drink plenty of fluids while you are taking this medicine. If you are experiencing severe diarrhoea after using this drug, discuss with your doctor immediately without any further delay.
Do not self-administer Macmika. It comes in the form of injection and given preferably 2 - 3 times in a day (Intravenously). Discontinuing the medicine in between may promote resistant bacteria which result in a relapse of the infection. You are recommended to complete the 7 - 10 days course even after getting symptomatic relief. In case you feel any discomfort such as hearing loss and nephrotoxicity while taking Macmika please inform your doctor immediately.
No, Macmika cannot be taken with penicillin. Because penicillin inactivates the Macmika by combining the beta-lactam ring of penicillin with an amino group of this drug to form amide which is biologically inactive. For this reason Macmika should not be taken with penicillin. The chances of inactivation of this drug are higher in case of renal failure because in this case concentration of penicillin is higher in the kidney for a longer time as compared to the normal renal function.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Arikayce (amikacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-137